Abstract
Exposure-response (ER) modelling (concentration-QTc analysis) is gaining as much acceptance as the traditional by-time analysis of the placebo-adjusted change from baseline in the QTc interval (ΔΔQTcF). It has been postulated that intensive ECG analysis and ER modelling during early-phase drug development could be a cost-effective approach of estimating QT liability of a new drug, in a small number of subjects. We used a highly automated analysis of ECGs from 46 subjects from a crossover thorough QT/QTc study to detect ΔΔQTcF with moxifloxacin. Using these data, we also simulated (bootstrapped) 1000 datasets of a parallel study with eight subjects receiving moxifloxacin and eight others receiving placebo. The slope from the concentration-QTc analysis for moxifloxacin in 46 subjects was 4.12 ms of ΔΔQTcF per μg(-1) mL(-1) ; at mean Cmax of 2.95 μg·mL(-1) , estimated ΔΔQTcF was 13.4 ms (90% confidence interval 11.3, 15.4 ms). In the 1000 simulated datasets, in 996 datasets, ER modelling showed that the upper bound of the 90% confidence interval for ΔΔQTcF at geometric mean Cmax exceeded 10 ms. In 895 of these 996 datasets, the slope of the ER relationship was statistically significantly positive. Thus, with a small sample size (e...Continue Reading
References
Aug 16, 2005·Journal of the American College of Cardiology·Charles M BeasleyRobert A Kloner
Apr 28, 2006·Journal of Clinical Pharmacology·Borje DarpoPhilip T Sager
Aug 22, 2006·Journal of Electrocardiology·Fabio Badilini, Nenad Sarapa
Dec 21, 2007·Journal of Clinical Pharmacology·Christine E GarnettJogarao V Gobburu
Sep 25, 2009·British Journal of Pharmacology·Vaibhav SalviSnehal Kothari
Feb 10, 2010·British Journal of Pharmacology·Jean-Pierre Valentin
Sep 21, 2010·Journal of Clinical Pharmacology·Mili NatekarDhiraj Narula
Dec 15, 2010·American Heart Journal·Paul KligfieldMitchell W Krucoff
Jan 14, 2011·Journal of Clinical Pharmacology·Jeffry A FlorianChristine E Garnett
Mar 20, 2012·American Heart Journal·Cynthia L GreenMitchell W Krucoff
Feb 19, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Norman StockbridgeChristine Garnett
Nov 16, 2013·Nucleic Acids Research·Adam J PawsonUNKNOWN NC-IUPHAR
Jun 12, 2014·The Journal of Pharmacology and Experimental Therapeutics·Erik SparveBjörn Paulsson
Nov 5, 2014·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Georg FerberBorje Darpo
Feb 12, 2015·Clinical Pharmacology and Therapeutics·B DarpoN Stockbridge
Jul 15, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Borje DarpoNorman Stockbridge
Dec 10, 2015·British Journal of Pharmacology·Stephen Ph AlexanderUNKNOWN CGTP Collaborators
Citations
Feb 22, 2018·Antimicrobial Agents and Chemotherapy·Marc WeinerWilliam R Mac Kenzie
Feb 25, 2020·Circulation Research·Pei-Chi YangColleen E Clancy
Sep 12, 2017·International Journal of Clinical Practice·Nicholas D BarwellUNKNOWN Scottish Diabetes Foot Action Group
Apr 20, 2018·Journal of Clinical Pharmacology·J Rick TurnerUNKNOWN Cardiac Safety Research Consortium
Aug 14, 2020·Toxins·Mojgan KavoosiRobert M Lester
Mar 16, 2018·The AAPS Journal·Nikunjkumar PatelSebastian Polak
Apr 1, 2017·European Heart Journal. Cardiovascular Pharmacotherapy·J Rick TurnerSnehal Kothari
Apr 21, 2021·Antimicrobial Agents and Chemotherapy·Vipul K GuptaDavid Melnick
Aug 1, 2018·Journal of Medicinal Chemistry·Takashi OdagiriHisashi Takahashi
Jul 22, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kendra K RadtkeAnthony J Garcia-Prats